# Huron Consulting Group Inc. (HURN)

> Source: Nexqual · https://nexqual.com/HURN · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Huron Consulting Group Inc. (HURN), nexqual.com/HURN" · informational, not investment advice.

**Price:** USD 193.35 (+5.47% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 183.32 · day 181.79–194.25 · 52w 84.88–194.25 · market cap $3.08B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $1.81B, net income $116M (6.4% margin), free cash flow $161M (SEC filings).
- Valuation: P/E 26.6x (avg 27.2x at the last 3 fiscal year-ends), EV/EBITDA 17.3x, net debt $802M.
- Insider open-market sales, last ~7 months: 11 Form 4 filings, $4.8M; 3 not under a Rule 10b5-1 plan ($570K); 1 by opportunistic insiders (0 outside 10b5-1 plans), 9 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.80 on a 1–5 scale) (5 analysts), mean target USD 190.75 (range 160–215).
- Total return with dividends: 1Y +26.3% vs S&P 500 +14.9%; 5Y +290.4% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 2.47, revenue estimate $481M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $927M | $1.16B | $1.40B | $1.52B | $1.70B | $1.81B |
| Gross profit | $265M | — | — | — | — | — |
| Operating income | $52.8M | $99.8M | $125M | $169M | $179M | $187M |
| Net income | $63.0M | $75.6M | $62.5M | $117M | $105M | $116M |
| EPS (diluted) | $2.89 | $3.64 | $3.19 | $6.27 | $5.84 | — |
| Free cash flow | $7.1M | $72.9M | $126M | $193M | $183M | $161M |
| Gross margin | 28.6% | — | — | — | — | — |
| Operating margin | 5.7% | 8.6% | 9.0% | 11.1% | 10.5% | 10.3% |
| Net margin | 6.8% | 6.5% | 4.5% | 7.7% | 6.2% | 6.4% |
| Revenue growth | +6.4% | +25.0% | +20.7% | +8.8% | +11.7% | — |
| Cash + short-term investments | $20.8M | $11.8M | $12.1M | $21.9M | $24.5M | — |
| Total debt | $233M | $290M | $324M | $357M | $510M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 26.6x · P/S 1.7x · EV/EBITDA 17.3x · EV/Sales 2.1x · P/FCF 19.1x · P/B 8.0x · FCF yield 5.23% · Earnings yield 3.76% · Buyback yield (TTM) 7.77% · Net debt $802M · EV $3.88B
P/E at fiscal year-ends: Dec 2025 29.6x, Dec 2024 19.8x, Dec 2023 32.3x.

## Insider sales (SEC Form 4, open-market, last ~7 months)
8 of 11 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Zumwalt Debra | Director | 82 | $14K | 0.3% | Yes (adopted May 15, 2026) | Routine (sold in Jan & Apr & Aug & Oct each year 2023–2025) |
| 2026-08-14 | Zumwalt Debra | Director | 82 | $13K | 0.3% | Yes (adopted May 15, 2026) | Routine (sold in Jan & Apr & Aug & Oct each year 2023–2025) |
| 2026-08-11 | Sawyer Hugh E Iii | Director | 2,000 | $309K | 8.9% | No | Routine (sold in Aug each year 2023–2025) |
| 2026-07-31 | Featherstone Kyle | Chief Acct Officer, Controller | 459 | $70K | 30.4% | No | Routine (sold in Aug each year 2023–2025; this trade is outside those months) |
| 2026-07-29 | Hussey C. Mark | CEO and President | 24,072 | $4.0M | 24.4% | Yes (adopted October 31, 2025) | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-22 | Brown Joy | Director | 1,821 | $191K | 17.5% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-05-11 | Singh-Bushell Ekta | Director | 443 | $52K | 3.1% | Yes (adopted May 15, 2025) | Routine (sold in Oct each year 2023–2025; this trade is outside those months) |
| 2026-05-11 | Zumwalt Debra | Director | 598 | $71K | 2.2% | Yes (adopted May 16, 2025) | Routine (sold in Jan & Apr & Aug & Oct each year 2023–2025; this trade is outside those months) |
| 2026-05-01 | McCartney John | Director | 500 | $66K | 1.2% | Yes (adopted August 15, 2024) | Routine (sold in Dec each year 2023–2025; this trade is outside those months) |
| 2026-04-02 | Singh-Bushell Ekta | Director | 126 | $16K | 0.9% | Yes (adopted May 15, 2025) | Routine (sold in Oct each year 2023–2025; this trade is outside those months) |
| 2026-04-02 | Zumwalt Debra | Director | 170 | $22K | 0.6% | Yes (adopted May 16, 2025) | Routine (sold in Jan & Apr & Aug & Oct each year 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 1.80 on a 1–5 scale), 5 analysts; mean target USD 190.75 (low 160, high 215).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +26.3% | +290.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +26.4% | +31.2% |
| Volatility (annualized) | 58.0% | 38.2% |
| Max drawdown | -51.4% (Jan 2026→Jun 2026) | -50.6% (Jan 2026→Jun 2026) |

## Peers (Consulting Services)
FCN (FTI Consulting, Inc.) USD 157.59 +5.50% · ICFI (ICF International, Inc.) USD 93.33 +3.76% · CRAI (CRA International,Inc.) USD 200.94 +9.59% · BAH (Booz Allen Hamilton Holding Cor) USD 78.57 +4.70% · SBC (SBC Medical Group Holdings Inco) USD 5.69 +2.71% · EFX (Equifax, Inc.) USD 187.14 +6.59%

## More
Full page: https://nexqual.com/HURN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in HURN's own 10-K filed 2026-02-24 (https://www.sec.gov/Archives/edgar/data/1289848/000162828026011093/hurn-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Oracle (ORCL) | "For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application…" |
| Partner | Salesforce (CRM) | "For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application…" |
| Partner | Microsoft (MSFT) | "For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application…" |
| Partner | Amazon (AMZN) | "For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application…" |
| Partner | SAP (SAP) | "For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application…" |
| Partner | Shorelight Holdings | "Convertible debt investment: Since 2014, we have invested $40.9 million, in the form of 1.69% convertible debt in Shorelight Holdings, LLC ("Shorelight"), the parent company of Shorelight, a U.S.-based company that partn…" |

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY | Operating income | Op. margin |
|---|---|---|---|---|---|
| Healthcare | $236.9M | 49.9% | +16.5% | $69.9M | 29.5% |
| Education | $142.2M | 29.9% | +8.0% | $37.4M | 26.3% |
| Commercial: | $96.0M | 20.2% | +25.0% | $19.8M | 20.6% |
| Total revenue | $475.0M | 100% | — | $127.1M | 26.7% |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $2.47 | $2.43 | +1.9% | $481.4M | 5 |
| Next quarter (ends 2026-12-31) | $2.57 | $2.50 | +2.6% | $481.3M | 5 |
| Current fiscal year (ends 2026-12-31) | $9.20 | $8.85 | +4.0% | $1.87B | 5 |
| Next fiscal year (ends 2027-12-31) | $10.59 | $10.22 | +3.6% | $2.04B | 5 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-03): ±13.3%; last 8 reports averaged ±13.5%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 58.2% | ±13.3% |
| 2026-12-18 | 56 | 49.7% | ±15.6% |
| 2027-03-19 | 147 | 48.4% | ±24.2% |
| 2027-06-17 | 237 | 48.1% | ±30.3% |